Study Title and Description
Evaluation of the BD Max Cdiff assay for the detection of toxigenic Clostridium difficile in human stool specimens.
Key Questions Addressed
|1||How do different methods for detection of toxigenic C. difficile to assist with diagnosis of CDI compare in their sensitivity, specificity, and predictive values? a. Overall? b. Do performance measures vary with sample characteristics? c. Does testing strategy impact patient health or health system outcomes?|
|2||What are effective prevention strategies? a. What is the effectiveness of current prevention strategies? b. What are the harms associated with prevention strategies? c. How sustainable are prevention practices in health care (outpatient, hospital inpatient, extended care) and community settings?|
|3||What is the comparative effectiveness and harms of different antibiotic treatments? a. Does effectiveness vary by disease severity?|
|4||What are the effectiveness and harms of other interventions? a. Overall b. In patients with relapse/recurrent CDI.|
Primary Publication Information
|Title||Evaluation of the BD Max Cdiff assay for the detection of toxigenic Clostridium difficile in human stool specimens.|
|Author||Putsathit P., Morgan J., Bradford D., Engelhardt N., Riley TV.|
|Country||1Microbiology and Immunology, School of Pathology and Laboratory Medicine, The University of Western Australia, Crawley 2Department of Microbiology and Infectious Diseases, PathWest Laboratory Medicine, Royal Perth Hospital, Perth 3Department of Microbiology, PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, Nedlands 4Department of Microbiology, PathWest Laboratory Medicine, Fremantle Hospital, Fremantle, WA, Australia.|
Pubmed ID: 25551308
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Detection, prevention, treatments, and efficacy and harms of interventions for C. difficile
Results & Comparisons
No Results found.